At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 31 enrolled
Drug / intervention
Vitamin E +2 moredrug
Likely dose
Vitamin E 400 IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis
In Brief
A Phase 4 clinical trial evaluating Vitamin E, Ropinirole, and 1 other intervention for Muscle Cramp and Cirrhosis. Completed, enrolled 31 participants across 1 site.
Detailed Summary
The investigator's aim is to compare the efficacy of Ropinirole (Requip) to vitamin E in the treatment of muscle cramps in cirrhotic patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMuscle Cramp, Cirrhosis
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2017201820192020202120222023202420252026
Enrollment StartSep 2016
First PostedJun 2017
Primary CompletionOct 2021
TodayJul 2026
First PostedJun 6, 2017
Enrollment StartSep 2, 2016
Primary CompletionOct 22, 2021
TodayJul 2, 2026
Enrollment to primary: 5.1 yearsPosted 9.1 years ago
Interventions
Vitamin Edrug
Patients will take 400 IU vitamin E nightly for 3 months.
Ropiniroledrug
Patients will take 0.5mg ropinirole nightly for 3 months.
Muscle cramp surveyother
Patients will complete a survey of muscle cramp frequency and severity at baseline, 3 months, and 6 months.